United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 409,000 | 408,200 | 412,600 | 369,000 | 404,900 |
| Cost of Goods | 28,400 | 23,600 | 20,000 | 700 | 25,300 |
| Gross Profit | 380,600 | 384,600 | 392,600 | 368,300 | 379,600 |
| Operating Expenses | 206,800 | 146,600 | 107,400 | 5,300 | 224,900 |
| Operating Income | 174,200 | 238,600 | 285,200 | 363,700 | 155,000 |
| Interest Expense | 2,200 | 500 | 600 | 600 | 500 |
| Other Income | -500 | 1,000 | 1,100 | 800 | 1,500 |
| Pre-tax Income | 171,500 | 239,100 | 285,700 | 363,900 | 156,000 |
| Income Tax | 61,200 | 77,300 | 79,600 | 128,400 | 51,400 |
| Net Income Continuous | 110,300 | 161,800 | 206,100 | 235,500 | 104,600 |
| Net Income | $110,300 | $161,800 | $206,100 | $235,500 | $104,600 |
| EPS Basic Total Ops | 2.70 | 3.75 | 4.65 | 5.19 | 2.18 |
| EPS Basic Continuous Ops | 2.71 | 3.75 | 4.65 | 5.19 | 2.16 |
| EPS Diluted Total Ops | 2.52 | 3.50 | 4.39 | 4.84 | 1.93 |
| EPS Diluted Continuous Ops | 2.52 | 3.50 | 4.39 | 4.84 | 1.92 |
| EBITDA(a) | $182,000 | $246,800 | $293,100 | $371,400 | $162,900 |